J. Borst

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis

L. M. Voortman, C. Hawkins, D. Roelen, 2020, Frontiers in Immunology.

Phase II evaluation of doxorubicin/vinblastine combined with inhibitors trifluoperazine/verapamil of P-glycoprotein in patients with advanced renal carcinoma.

B. Blumenstein, J. Borst, R. Flanigan, 1997, Urologic oncology.

Rearrangement and expression of T-cell receptor delta genes in T-cell acute lymphoblastic leukemias.

J. V. van Dongen, P. J. van den Elsen, J. Borst, 1989, Blood.

Phase II and pharmacokinetic study of high-dose methotrexate in the treatment of advanced gynecologic malignancy. A Southwest Oncology Group Trial.

D. Alberts, B. Skipper, J. Standefer, 1984, Gynecologic oncology.

Development of human T lymphocytes and their thymus-dependency.

J. V. van Dongen, J. Borst, W. Comans-Bitter, 1990, Thymus.

Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.

J. Borst, Yanling Xiao, C. van den Bos, 2020, Blood.

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

W. McGuire, P. Ravdin, C. Fabian, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

T. van Wezel, C. V. van Noesel, C. Hutter, 2022, Blood advances.

Polyclonal expansion of T-cell receptor-gamma delta+ T lymphocytes associated with neutropenia and thrombocytopenia.

R. Brandt, J. V. van Dongen, C. Melief, 1992, Leukemia.

A UNIQUE IMMUNE SIGNATURE IN BLOOD SEPARATES THERAPY-REFRACTORY FROM THERAPY-RESPONSIVE ACUTE GRAFT-VERSUS-HOST DISEASE.

R. Tsonaka, W. Fibbe, J. Zwaginga, 2022, Blood.

Phase II study of thymosin fraction 5 in the treatment of metastatic renal cell carcinoma.

N. Dimitrov, D. Arnold, P. Stott, 1985, Cancer treatment reports.